2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Modulation of Klotho expression in injured muscle perturbs Wnt signalling and influences the rate of muscle growth

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Skeletal muscle injuries activate a complex program of myogenesis that can restore normal muscle structure. We tested whether modulating the expression of klotho influenced the response of mouse muscles to acute injury. Our findings show that klotho expression in muscle declines at 3-days post-injury. That reduction in klotho expression coincided with elevated expression of targets of Wnt signaling ( Ccnd1 ; Myc ) and increased MyoD+ muscle cell numbers, reflecting the onset of myogenic cell differentiation. Klotho expression subsequently increased at 7-days post-injury with elevated expression occurring primarily in inflammatory lesions, which was accompanied by reduced expression of Wnt target genes ( Ccnd1 : 91%; Myc : 96%). Introduction of a klotho transgene maintained high levels of klotho expression over the course of muscle repair and attenuated the increases in Ccnd1 and Myc expression that occurred at 3-days post-injury. Correspondingly, transgene expression reduced Wnt signaling in Pax7+ cells, reflected by reductions in Pax7+ cells expressing active β-catenin, and reduced the numbers of MyoD+ cells at 3-days post-injury. At 21-days post-injury, muscles in klotho transgenic mice showed increased Pax7+ and decreased myogenin+ cell densities and large increases in myofiber size. Likewise, treating myogenic cells in vitro with Klotho reduced Myod expression but did not affect Pax7 expression. Muscle inflammation was only slightly modulated by increased klotho expression, initially reducing the expression of M2-biased macrophage markers Cd163 and Cd206 at 3-days post-injury and later increasing the expression of pan-macrophage marker F480 and Cd68 at 21-days post-injury. Collectively, our study shows that Klotho modulates myogenesis and that increased expression accelerates muscle growth after injury.

          Related collections

          Most cited references1

          • Record: found
          • Abstract: found
          • Article: not found

          Klotho gene silencing promotes pathology in themdxmouse model of Duchenne muscular dystrophy

          Duchenne muscular dystrophy (DMD) is a lethal muscle disease involving progressive loss of muscle regenerative capacity and increased fibrosis. We tested whether epigenetic silencing of the klotho gene occurs in the mdx mouse model of DMD and whether klotho silencing is an important feature of the disease. Our findings show that klotho undergoes muscle-specific silencing at the acute onset of mdx pathology. Klotho experiences increased methylation of CpG sites in its promoter region, which is associated with gene silencing, and increases in a repressive histone mark, H3K9me2. Expression of a klotho transgene in mdx mice restored their longevity, reduced muscle wasting, improved function and greatly increased the pool of muscle-resident stem cells required for regeneration. Reductions of fibrosis in late, progressive stages of the mdx pathology achieved by transgene expression were paralleled by reduced expression of Wnt target genes (axin-2), transforming growth factor-beta (TGF-β1) and collagens types 1 and 3, indicating that Klotho inhibition of the profibrotic Wnt/TGFβ axis underlies its anti-fibrotic effect in aging, dystrophic muscle. Thus, epigenetic silencing of klotho during muscular dystrophy contributes substantially to lost regenerative capacity and increased fibrosis of dystrophic muscle during late progressive stages of the disease.
            Bookmark

            Author and article information

            Contributors
            (View ORCID Profile)
            Journal
            Experimental Physiology
            Exp Physiol
            Wiley
            0958-0670
            1469-445X
            January 2020
            December 16 2019
            January 2020
            : 105
            : 1
            : 132-147
            Affiliations
            [1 ]Department of Integrative Biology and Physiology University of California Los Angeles CA 90095 USA
            [2 ]Indiana University School of Medicine Indianapolis IN 46202 USA
            [3 ]Division of Anti‐Aging Medicine Center for Molecular Medicine Jichi Medical University 3311‐1 Yakushiji Shimotsuke Tochigi 329–0498 Japan
            [4 ]Molecular, Cellular & Integrative Physiology Program University of California Los Angeles CA 90095 USA
            [5 ]Department of Pathology and Laboratory Medicine David Geffen School of Medicine at UCLA University of California Los Angeles CA 90095 USA
            Article
            10.1113/EP088142
            6938556
            31724771
            7263765e-3a14-461e-b8ef-8fa5b0fcc598
            © 2020

            http://onlinelibrary.wiley.com/termsAndConditions#vor

            http://doi.wiley.com/10.1002/tdm_license_1.1

            History

            Comments

            Comment on this article